Development and Validation of Pomalidomide Determination in Human Plasma by HPLC-MS/MS Method

Introduction. B-cell malignancies of the plasma cell leads to the second most spread hematological malignancy disease, called multiple myeloma. Pomalidomide is used in case of previous multiple myeloma ineffective treatment. Pomalidomide is a thalidomide synthetic derived, approved as immunomodulato...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: T. N. Komarov, I. E. Shohin, M. A. Tokareva, O. A. Archakova, D. S. Bogdanova, A. A. Aleshina, N. S. Bagaeva, V. V. Davydanova, N. P. Sadchikova
स्वरूप: Artigo
भाषा:Russo
प्रकाशित: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2020-11-01
श्रृंखला:Разработка и регистрация лекарственных средств
विषय:
pomalidomide
plasma
hplc-ms/ms
validation
bioequivalence
ऑनलाइन पहुंच:https://www.pharmjournal.ru/jour/article/view/864
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन